High Throughput ELISAs to Measure a Unique Glycan on Transferrin in Cerebrospinal Fluid: A Possible Extension toward Alzheimer's Disease Biomarker Development
2011

High Throughput ELISAs for Measuring Glycans on Transferrin in Cerebrospinal Fluid

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): Keiro Shirotani, Satoshi Futakawa, Kiyomitsu Nara, Kyoka Hoshi, Toshie Saito, Yuriko Tohyama, Shinobu Kitazume, Tatsuhiko Yuasa, Masakazu Miyajima, Hajime Arai, Atsushi Kuno, Hisashi Narimatsu, Yasuhiro Hashimoto

Primary Institution: Fukushima Medical University School of Medicine

Hypothesis

Can high-throughput lectin-antibody ELISAs distinguish between different glycoforms of transferrin in cerebrospinal fluid for diagnosing idiopathic normal pressure hydrocephalus?

Conclusion

The study found that SSA-reactive transferrin levels were significantly higher in cerebrospinal fluid from patients with idiopathic normal pressure hydrocephalus compared to non-iNPH patients.

Supporting Evidence

  • The lectin-antibody ELISAs can distinguish between CSF-type and serum-type transferrin.
  • SSA-reactive transferrin levels were significantly higher in iNPH patients.
  • The developed ELISAs are high throughput and suitable for clinical use.
  • Previous methods like immunoblotting were impractical for clinical use due to low throughput.
  • The study suggests potential for these ELISAs in diagnosing other neurological diseases.

Takeaway

The researchers created a new test to measure specific sugars on a protein in the brain fluid, which could help doctors tell if someone has a certain type of dementia.

Methodology

The study used high-throughput lectin-antibody ELISAs to measure different glycoforms of transferrin in cerebrospinal fluid samples from patients.

Limitations

The study focused only on idiopathic normal pressure hydrocephalus and did not explore other neurological diseases in depth.

Participant Demographics

28 iNPH patients (14 males, 14 females) aged 75.2 ± 6.1 years and 18 non-iNPH patients (10 males, 8 females) aged 74.9 ± 5.2 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4061/2011/352787

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication